General Evaluator, Clinical Trial Patient Experience jobs in United States
cer-icon
Apply on Employer Site
company-logo

Hippocratic AI · 1 day ago

General Evaluator, Clinical Trial Patient Experience

Hippocratic AI has developed a groundbreaking Large Language Model for healthcare, aiming to revolutionize patient outcomes. The Clinical Trial Patient Experience Evaluator will assess AI-led recruitment and screening calls to ensure compliance with protocols and guidelines while providing structured feedback.

Artificial Intelligence (AI)Foundational AIGenerative AIHealth CareInformation Technology
check
Growth Opportunities

Responsibilities

Review and assess patient-facing Voice AI interactions
Listen to and speak with AI-led recruitment and screening calls
Evaluate whether the agent sounds appropriate, follows protocols and regulatory guidelines, and handles patient interactions correctly
Document structured feedback across predefined criteria

Qualification

Clinical trial recruitmentPatient-facing operationsCommunication skillsAI performance evaluationTechnical tools experienceFluency in additional languageFluency in English

Required

2–5+ years of experience in clinical trial recruitment or patient-facing clinical operations (site, CRO, or call-based teams)
Experience engaging with patients or reviewing patient-facing recruitment, screening, or follow-up interactions
Strong written and verbal communication skills
Ability to make clear, accurate judgment calls when evaluating AI performance (tone, accuracy, and protocol adherence)
Fluency in English
Reliable access to a computer and high-speed internet

Preferred

Fluency in an additional language
Experience using technical or software-based tools (e.g., CRMs, CTMS, call review platforms)
Prior exposure to AI, digital health, or call quality review

Company

Hippocratic AI

twittertwittertwitter
company-logo
Hippocratic AI is a healthcare technology company that develops safety-focused large-language models for medical applications.

Funding

Current Stage
Growth Stage
Total Funding
$402M
Key Investors
AvenirKleiner PerkinsNVentures
2025-11-03Series C· $126M
2025-01-09Series B· $141M
2024-09-19Series A· $17M

Leadership Team

leader-logo
Alex Miller
Co-Founder
linkedin
leader-logo
Amy McCarthy
Chief Nursing Officer
linkedin
Company data provided by crunchbase